Skip to main content

US BANCORP \DE\

Bank

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 36104 MINNEAPOLIS, MN

Position in TEVA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,480,785
+$3,843,261 QoQ
Shares Held
181,965
+246.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 97.7226389690325.ToString("F0")% Shared 0.ToString("F0")% None 2.277361030967494.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

US BANCORP \DE\ holds $39,051,582 across 40 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (14.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 TEVA
Teva Pharmaceutical Industries Ltd
This page
181,965 $5,480,785

All Filings in TEVA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,480,785 181,965
2025-12-31 $1,637,524 52,468
2025-09-30 $197,433 9,774
2025-06-30 $163,593 9,761
2025-03-31 $166,179 10,812
2024-12-31 $223,836 10,156
2024-09-30 $173,567 9,632
2024-06-30 $374,334 23,036
2024-03-31 $115,559 8,190
2023-12-31 $39,963 3,828
2023-09-30 $28,610 2,805
2023-06-30 $13,742 1,825
2023-03-31 $89,561 10,120
2022-12-31 $96,187 10,547
2022-09-30 $86,388 10,705
2022-06-30 $76,658 10,194
2022-03-31 $106,415 11,333
2021-12-31 $93,700 11,698
2021-09-30 $112,165 11,516
2021-06-30 $123,818 12,507
2021-03-31 $166,948 14,467
2020-12-31 $154,554 16,016
2020-09-30 $146,105 16,216
2020-06-30 $234,257 18,999
2020-03-31 $175,234 19,514